A pan-cancer analysis revealed that STAR is expressed not only in ovarian cancer but also in other tumors, such as head and neck squamous cell carcinoma (HNSC), testicular germ cell tumors (TGCT), low-grade glioma (LGG), and lung squamous cell carcinoma (LUSC) (Figure 2A). Here, STAR is linked to ovarian carcinoma.